Garzino-Demo A, DeVico A L, Gallo R C
Institute of Human Virology, University of Maryland, Baltimore 21201-1192, USA.
J Clin Immunol. 1998 Jul;18(4):243-55. doi: 10.1023/A:1027329721892.
Suppression of HIV by chemokines represents a special case in virology and immunology where soluble molecules other than antibodies inhibit infection by a specific virus. The basis for this inhibition is that HIV has evolved to use certain chemokine receptors as "coreceptors" for entry into host cells. Human genotypes that reduce or prevent coreceptor expression are strongly associated with protection against infection and slower disease progression. We suggest that local production of certain chemokines can produce a similar modulation of coreceptor expression, and mounting evidence indicates that chemokine release is a major determinant of protection from HIV infection. Here we review this evidence and explore future avenues for investigating the role of chemokines in controlling HIV infection.
趋化因子对HIV的抑制作用代表了病毒学和免疫学中的一个特殊案例,即除抗体外的可溶性分子可抑制特定病毒的感染。这种抑制作用的基础是HIV已经进化到利用某些趋化因子受体作为进入宿主细胞的“共受体”。减少或阻止共受体表达的人类基因型与预防感染和减缓疾病进展密切相关。我们认为,某些趋化因子的局部产生可对共受体表达产生类似的调节作用,而且越来越多的证据表明趋化因子的释放是预防HIV感染的主要决定因素。在此,我们综述这方面的证据,并探索未来研究趋化因子在控制HIV感染中作用的途径。